ClearPoint Neuro, Inc. Share Price
Equities
CLPT
US18507C1036
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | -0.94% | -1.31% | -22.53% |
Sales 2024 * | 30.26M 2.52B | Sales 2025 * | 42.77M 3.57B | Capitalization | 142M 11.87B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.67B | Net income 2025 * | -19M -1.58B | EV / Sales 2024 * | 4.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
-6.95
x | P/E ratio 2025 * |
-7.44
x | Employees | 107 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.4% |
Latest transcript on ClearPoint Neuro, Inc.
1 day | -0.94% | ||
1 week | -1.31% | ||
Current month | -22.65% | ||
1 month | -21.73% | ||
3 months | -24.64% | ||
6 months | +1.54% | ||
Current year | -22.53% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07/17/07 |
Director of Finance/CFO | 39 | 29/20/29 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 10/22/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 01/19/01 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 15/21/15 |
R. Fletcher
CHM | Chairman | 78 | 09/17/09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.26 | -0.94% | 168,814 |
25/24/25 | 5.31 | -0.19% | 151,452 |
24/24/24 | 5.32 | -3.27% | 59,294 |
23/24/23 | 5.5 | -0.18% | 55,240 |
22/24/22 | 5.51 | +3.38% | 48,516 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.53% | 142M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- CLPT Stock